Key facts
- This page summarizes Brian West's Form 4 filing for BOEING CO (BA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 21 Feb 2025, 21:15.
Brian West - 19 Feb 2025 Form 4 Insider Report for BOEING CO (BA)
- Reporting relationship
- EVP & Chief Financial Officer
- Issuer ticker
- BA
- Reported as of
- 19 Feb 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 Feb 2025, 21:15:41 UTC
- Prior SEC filing
- 20 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Dana Kumar, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Brian West filed Form 4 for BOEING CO (BA) on 21 Feb 2025.
Change
- Previous filing in this sequence was filed on 20 Feb 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BA
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +14,631
- Change %
- +33%
- Price
- $0.000000
- Shares after
- 59,065
- Date
- 19 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
BA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 811
- Date
- 19 Feb 2025
- Ownership
- 401(k) plan
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BA
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +41,493
- Change %
- Price
- $0.000000
- Shares after
- 41,493
- Date
- 19 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 41,493
- Exercise price
- $221.44
- Footnotes
- F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Represents restricted stock units of which 4,828 units will vest on February 19, 2026, 4,828 units will vest on February 19, 2027, and 4,975 units will vest on February 22, 2028; units settle in shares of the Company's common stock on a one-for-one basis.
Footnote F2
Ownership in the issuer's 401(k) plan is represented by units in the issuer's common stock fund in the plan rather than shares of common stock.
Footnote F3
The exercise price is equal to 120% of the average of the high and low trading prices on the date of grant.
Footnote F4
The option becomes vested and and exercisable in full on February 19, 2028, which is the third anniversary of the date of grant.